Evidence map›Paper›PMID 36537898›Full record

Trial reportRadiology2023

Radiographic Cortical Thickness Index Predicts Fragility Fracture in Gaucher Disease.

Simona D'Amore, Hiroshige Sano, Daniel David George Chappell, Davide Chiarugi, Olivia Baker, Kathleen Page, Uma Ramaswami, Fjola Johannesdottir, Timothy M Cox, Patrick Deegan and 3 more

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03240653 (Predictive Measures to Stratify Clinical Outcomes in Children and Adults With Gaucher Disease and Responses to Specific Therapies), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03240653 recruitingnot on this map

Predictive Measures to Stratify Clinical Outcomes in Children and Adults With Gaucher Disease and Responses to Specific Therapies

TypeobservationalSponsorCambridge University Hospitals NHS Foundation TrustRan2014 to 2028Enrolled250ConditionsGaucher Disease, Type I, Gaucher Disease, Type IIIArmsStratified response to Enzyme Therapy
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 3 countries.

Simona D'AmoreFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0002-5432-8808
Hiroshige SanoFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).
Daniel David George ChappellFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0002-1958-6246
Davide ChiarugiFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0003-2752-3189
Olivia BakerFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0002-0038-2657
Kathleen PageFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0002-7673-6685
Uma RamaswamiFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0002-4703-7447
Fjola JohannesdottirFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0003-3054-9152
Timothy M CoxFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0002-4951-9941
Patrick DeeganFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0001-9427-9900
Kenneth E PooleFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).ORCID 0000-0003-4546-7352
MRC Gaucherite ConsortiumFrom the Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Hills Rd, Cambridge CB2 0QQ, UK (S.D., H.S., D.D.G.C., O.B., K.P., F.J., T.M.C., P.D., K.E.P.); The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK (D.C.); and Royal Free London NHS Foundation Trust, London, UK (U.R.).
MRC Gaucherite Consortium Collaborators
Wellcome/MRC Institute of Metabolic Science · GBUniversity of Cambridge · GBGreat Ormond Street Hospital · GBBirmingham Women's Hospital · GBManchester University NHS Foundation Trust · GBNational Hospital for Neurology and Neurosurgery · GBQueen Elizabeth Hospital Birmingham · GBSalford Royal Hospital · GBSt. Mary’s Hospital · ZAThe Royal Free Hospital · GBUniversity of Oxford · GB

Funding

Department of Health PB-PG-0816-20027
6 · The paper itself

Abstract

Background Patients with Gaucher disease (GD) have a high risk of fragility fractures. Routine evaluation of bone involvement in these patients includes radiography and repeated dual-energy x-ray absorptiometry (DXA). However, osteonecrosis and bone fracture may affect the accuracy of DXA. Purpose To assess the utility of DXA and radiographic femoral cortical thickness measurements as predictors of fragility fracture in patients with GD with long-term follow-up (up to 30 years). Materials and Methods Patients with GD age 16 years and older with a detailed medical history, at least one bone image (DXA and/or radiographs), and minimum 2 years follow-up were retrospectively identified using three merged UK-based registries (Gaucherite study, enrollment 2015-2017; Clinical Bone Registry, enrollment 2003-2006; and Mortality Registry, enrollment 1993-2019). Cortical thickness index (CTI) and canal-to-calcar ratio (CCR) were measured by two independent observers, and inter- and intraobserver reliability was calculated. The fracture-predictive value of DXA, CTI, CCR, and cutoff values were calculated using receiver operating characteristic curves. Statistical differences were assessed using univariable and multivariable analysis. Results Bone imaging in 247 patients (123 men, 124 women; baseline median age, 39 years; IQR, 27-50 years) was reviewed. The median follow-up period was 11 years (IQR, 7-19 years; range, 2-30 years). Thirty-five patients had fractures before or at first bone imaging, 23 patients had fractures after first bone imaging, and 189 patients remained fracture-free. Inter- and intraobserver reproducibility for CTI/CCR measurements was substantial (range, 0.96-0.98). In the 212 patients with no baseline fracture, CTI (cutoff, ≤0.50) predicted future fractures with higher sensitivity and specificity (area under the receiver operating characteristic curve [AUC], 0.96; 95% CI: 0.84, 0.99; sensitivity, 92%; specificity, 96%) than DXA T-score at total hip (AUC, 0.78; 95% CI: 0.51, 0.91; sensitivity, 64%; specificity, 93%), femoral neck (AUC, 0.73; 95% CI: 0.50, 0.86; sensitivity, 64%; specificity, 73%), lumbar spine (AUC, 0.69; 95% CI: 0.49, 0.82; sensitivity, 57%; specificity, 63%), and forearm (AUC, 0.78; 95% CI: 0.59, 0.89; sensitivity, 70%; specificity, 70%). Conclusion Radiographic cortical thickness index of 0.50 or less was a reliable independent predictor of fracture risk in Gaucher disease. Clinical trial registration no. NCT03240653 © RSNA, 2022

Indexed as

Fractures, BoneGaucher DiseaseOsteoporotic FracturesAbsorptiometry, PhotonAdolescentAdultBone DensityFemaleHumansMaleReproducibility of ResultsRetrospective StudiesTomography, X-Ray Computed

Identifiers

PMID36537898
PMCPMC7614382
OpenAlexW4311993121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.